BioSpace News Archive

Galmed Pharmaceuticals Ltd. announced that the company has completed its End-of-Phase 2 meeting with the Food and Drug Administration and reached general agreement on key aspects of the Phase 3/4 development and registration plan for Aramchol and on the pivotal registration study ARMOR.

United American Healthcare Corporation announced that American Sustainable Rubber Company, LLC and The Ohio State University signed a royalty agreement for exclusive rights within the United States to the genetically modified TK Rubber Dandelion, developed at The Ohio State University, to be grown in an indoor hydroponic system for natural rubber production.

Aldeyra Therapeutics, Inc. announced that John Sheppard, M.D., Professor of Ophthalmology at Eastern Virginia Medical School, will present results of the Phase 2b clinical trial of topical reproxalap in dry eye disease at the Association for Research in Vision and Ophthalmology 2019 Annual Meeting held April 28 through May 2, 2019, in Vancouver, Canada.

Nationally Renowned Dementia Expert Teepa Snow Partners with Leading In-Home Senior Care Provider to Deliver Valuable Caregiving Insights

Fraternity members nationwide band together to achieve fundraising commitment for children fighting cancer and other life-threatening diseases

SAKIGAKE Designation will provide development support and accelerated review of valemetostat, an investigational and potential first-in-class EZH1/2 dual inhibitor, for relapsed/refractory peripheral T-cell lymphoma (PTCL)

Groundbreaking XT MicroSlides Deliver Accurate Results from 2 Simultaneous Miniaturized Tests, Simplifying Workflow and Improving Turnaround Time in the Lab

Nearly $525,000 in Funds and Health Care Products Donated to Support 12 Pediatric Health Programs

The company is expanding its software-as-a-medical-device platform to support the optimization of ALL diabetes medications.

Strategic collaboration will bolster 22nd Century’s position as a global leader in hemp/cannabis genetics.